TP53 and Miyoshi myopathy: In addition to confirming frequently mutated MM genes (e.g., KRAS, BRAF, TENT5C, and TP53), this approach identified low-frequency potential new driver mutations (e.g., SUZ12, CRBN, SELENOT, and ZNF484, Figure 1G and Table S4).